(Q73665603)
Statements
A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2 (English)
Rosenberg SA
Ohnmacht GA
Phan GQ
Mavroukakis SA
Steinberg SM
Shea YR
Witebsky FG
McIntyre LS
Goodwin RS
Muehlbauer PM
Morton KE
Rogers-Freezer LJ
Seipp CA